Relationships between cancer and aging: a multilevel approach - PubMed
Review
Relationships between cancer and aging: a multilevel approach
Vladimir N Anisimov et al. Biogerontology. 2009 Aug.
Abstract
The incidence of cancer increases with age in humans and in laboratory animals alike. There are different patterns of age-related distribution of tumors in different organs and tissues. Aging may increase or decrease the susceptibility of various tissues to initiation of carcinogenesis and usually facilitates promotion and progression of carcinogenesis. Aging may predispose to cancer in two ways: tissue accumulation of cells in late stages of carcinogenesis and alterations in internal homeostasis, in particular, alterations in immune and endocrine systems. Increased susceptibility to the effects of tumor promoters is found both in aged animals and aged humans, as predicted by the multistage model of carcinogenesis. Aging is associated with a number of events at the molecular, cellular and physiological levels that influence carcinogenesis and subsequent cancer growth. An improved understanding of age-associated variables impacting on the tumor microenvironment, as well as the cancer cells themselves, will result in improved treatment modalities in geriatric oncology.
Similar articles
-
Carcinogenesis and aging 20 years after: escaping horizon.
Anisimov VN. Anisimov VN. Mech Ageing Dev. 2009 Jan-Feb;130(1-2):105-21. doi: 10.1016/j.mad.2008.02.004. Epub 2008 Feb 15. Mech Ageing Dev. 2009. PMID: 18372004 Review.
-
Anisimov VN. Anisimov VN. Adv Gerontol. 2002;10:99-125. Adv Gerontol. 2002. PMID: 12577699 Review. Russian.
-
The relationship between aging and carcinogenesis: a critical appraisal.
Anisimov VN. Anisimov VN. Crit Rev Oncol Hematol. 2003 Mar;45(3):277-304. doi: 10.1016/s1040-8428(02)00121-x. Crit Rev Oncol Hematol. 2003. PMID: 12633840 Review.
-
Anisimov VN. Anisimov VN. Cancer Control. 2007 Jan;14(1):23-31. doi: 10.1177/107327480701400104. Cancer Control. 2007. PMID: 17242668 Review.
-
Prevention of carcinogenesis by protease inhibitors.
Kennedy AR. Kennedy AR. Cancer Res. 1994 Apr 1;54(7 Suppl):1999s-2005s. Cancer Res. 1994. PMID: 8137328 Review.
Cited by
-
Queen BL, Tollefsbol TO. Queen BL, et al. Curr Aging Sci. 2010 Feb;3(1):34-42. doi: 10.2174/1874609811003010034. Curr Aging Sci. 2010. PMID: 20298168 Free PMC article. Review.
-
Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy.
Flies DB, Sandler BJ, Sznol M, Chen L. Flies DB, et al. Yale J Biol Med. 2011 Dec;84(4):409-21. Yale J Biol Med. 2011. PMID: 22180678 Free PMC article. Review.
-
Quality of Life and Side Effects Management in Cancer Treatment-A Cross Sectional Study.
Llamas-Ramos I, Alvarado-Omenat JJ, Rodrigo-Reguilón M, Llamas-Ramos R. Llamas-Ramos I, et al. Int J Environ Res Public Health. 2023 Jan 17;20(3):1708. doi: 10.3390/ijerph20031708. Int J Environ Res Public Health. 2023. PMID: 36767073 Free PMC article.
-
Lu L, Ma L, Zhang X, Susanne Mullins C, Linnebacher M. Lu L, et al. Cancer Med. 2021 Apr;10(8):2740-2751. doi: 10.1002/cam4.3673. Epub 2020 Dec 13. Cancer Med. 2021. PMID: 33314795 Free PMC article.
-
Metformin in obesity, cancer and aging: addressing controversies.
Berstein LM. Berstein LM. Aging (Albany NY). 2012 May;4(5):320-9. doi: 10.18632/aging.100455. Aging (Albany NY). 2012. PMID: 22589237 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical